Becton Dickinson AI Adoption Tracker
Last updated: August 9, 2026
Overview
Becton Dickinson (BD) has emerged as a strategic AI adopter in the medical technology sector, positioning AI as central to its transformation into a 'pure-play MedTech leader.' BD launched the BD Incada™ Connected Care Platform in October 2025, an AI-enabled, cloud-based platform that unifies data from nearly 3 million connected BD devices into one intelligent ecosystem[1][2]. The company has developed AI-powered solutions across multiple business areas, including the BD Kiestra™ MRSA application for laboratory automation with AI-assisted plate reading[3], the BD HealthSight™ Diversion Management software using advanced AI to detect controlled substance diversion in operating rooms[4], and strategic partnerships like the collaboration with Techcyte for AI-based digital cervical cytology systems[5]. Under CEO Tom Polen's leadership, BD has positioned 2025 as a pivotal year for leveraging 'significant shifts in technology, like biologics, AI and automation, that are revolutionizing patient care'[6].
- [1] BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
- [2] BD Incada™ Platform
- [3] BD tech chief Beth McCombs talks about Parata acquisition, automation
- [4] New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
- [5] BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
- [6] BD Q4 FY2024 10-K Filing
AI Maturity Index
Radar Comparison
Peer Comparison: Becton Dickinson vs healthcare
Based on 66 companies in sector
| Dimension | Becton Dickinson | Sector Avg | Diff |
|---|---|---|---|
| Adoption | 4.0 | 3.7 | +0.3 |
| Proficiency | 3.0 | 3.5 | -0.5 |
| Impact | 3.0 | 3.6 | -0.6 |
| Overall | 3.3 | 3.6 | -0.3 |
AI Hiring Signals
Becton Dickinson Job Postings Analysis
Tech vs Non-Tech AI Requirements
Non-tech AI adoption exceeds tech roles - strong org-wide AI fluency signal
Top Departments by AI Mention Rate
Analysis
BD shows minimal AI hiring emphasis with only 1.4% of job postings mentioning AI. Notably, tech roles show 0% AI mentions while non-tech roles show 1.7%, suggesting AI adoption is primarily driven by business functions rather than core technology teams.
View Sample Job Postings (5 sources)
Key Metrics
AI Initiatives
BD Incada™ Connected Care Platform
October 20, 2025
AI-enabled, cloud-based platform that unifies BD device data into one intelligent ecosystem
Built on AWS infrastructure with natural language analytics, scalable to meet data volumes from nearly 3 million smart connected BD devices. Provides enterprise-wide visibility into medication inventory with AI-powered insights and customizable dashboards.
HemoSphere Alta™ Advanced Monitoring Platform
April 21, 2025
Next-generation hemodynamic monitoring with AI-driven clinical decision support
Features predictive AI algorithms to help clinicians proactively address blood pressure instability and optimize blood flow during critical procedures.
BD HealthSight™ Diversion Management with AI
September 26, 2024
Advanced AI software to detect controlled substance diversion in operating rooms
Uses artificial intelligence to identify patterns and indicators of controlled substance diversion by healthcare workers, particularly effective in operating room environments.
BD Advanced Patient Monitoring with AI
September 3, 2024
Integration of AI-enabled clinical decision tools through Edwards Lifesciences acquisition
Acquired Edwards' Critical Care product group including advanced AI algorithm clinical decision support tools for smart connected care solutions.
BD-Techcyte AI Cervical Cytology Collaboration
January 30, 2024
Strategic partnership for AI-based digital cervical cytology system
AI algorithm guides cytologists and pathologists to efficiently identify evidence of cervical cancer and precancer using whole-slide imaging, reducing human error and enabling greater throughput.
Frequently Asked Questions
BD Incada™ Connected Care Platform is BD's AI-enabled, cloud-based platform that unifies data from nearly 3 million BD devices into one intelligent ecosystem, launched in October 2025.
BD uses AI through the HealthSight™ Diversion Management software to detect controlled substance diversion and the Incada™ platform to provide enterprise-wide visibility into medication inventory with AI-powered insights.
BD's Kiestra™ MRSA application uses AI-powered computer vision to automatically triage bacterial culture plates, distinguishing between plates with no growth versus those requiring technician attention.
Yes, BD acquired Edwards Lifesciences' Critical Care product group in September 2024, which includes advanced AI algorithm clinical decision support tools for patient monitoring.
Key partnerships include Techcyte for AI-based cervical cytology systems, AWS for cloud infrastructure, and Mayo Clinic Platform for AI/ML-powered post-market surveillance using real-world data.
In Application
| Application | Vendor | Use Case |
|---|---|---|
| Amazon Web Services AI/ML Services | Amazon | Cloud infrastructure and AI analytics for BD Incada™ Platform |
| Natural Language Processing | Internal/AWS | Natural language search capabilities in analytics platform |
Sources
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
BD Incada™ Platform
BD tech chief Beth McCombs talks about Parata acquisition, automation
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
BD Q4 FY2024 10-K Filing
Becton Dickinson CEO Tom Polen discusses how AI can revolutionize health care
Becton Dickinson and Co in artificial intelligence: Theme innovation strategy
Related Companies
About AI Tracker
AI Tracker is a research project by Larridin, the AI execution intelligence platform.
Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.
Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.